George E. Moore

3.0k total citations · 1 hit paper
65 papers, 2.0k citations indexed

About

George E. Moore is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, George E. Moore has authored 65 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Immunology and 15 papers in Molecular Biology. Recurrent topics in George E. Moore's work include Immunotherapy and Immune Responses (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and T-cell and B-cell Immunology (7 papers). George E. Moore is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and T-cell and B-cell Immunology (7 papers). George E. Moore collaborates with scholars based in United States, Germany and Japan. George E. Moore's co-authors include Avery A. Sandberg, Linda K. Woods, Robert T. Morgan, R. Gerner, Jun Minowada, Takaaki Ishihara, Akihiko Koike, Harm HogenEsch, Helvise G. Morse and Jack Thomas and has published in prestigious journals such as Science, Journal of the American Chemical Society and JAMA.

In The Last Decade

George E. Moore

60 papers receiving 1.7k citations

Hit Papers

Culture of Normal Human Leukocytes 1967 2026 1986 2006 1967 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George E. Moore United States 22 657 546 353 263 219 65 2.0k
John C. Marsh United States 25 646 1.0× 526 1.0× 273 0.8× 337 1.3× 228 1.0× 65 2.1k
Goro Kōsaki Japan 28 1.2k 1.9× 605 1.1× 257 0.7× 140 0.5× 242 1.1× 110 2.9k
R. C. Nairn Australia 27 747 1.1× 555 1.0× 819 2.3× 270 1.0× 220 1.0× 123 2.5k
Leonard S. Kaplow United States 16 465 0.7× 247 0.5× 876 2.5× 251 1.0× 239 1.1× 31 2.5k
P Rümke Netherlands 27 851 1.3× 534 1.0× 413 1.2× 202 0.8× 217 1.0× 63 2.8k
Hannah Ben‐Bassat Israel 30 1.2k 1.9× 399 0.7× 524 1.5× 314 1.2× 174 0.8× 98 2.5k
R Whitehead Australia 25 844 1.3× 619 1.1× 339 1.0× 262 1.0× 423 1.9× 74 2.3k
Tommie Sue Tralka United States 19 828 1.3× 506 0.9× 269 0.8× 698 2.7× 463 2.1× 35 2.5k
J. F. Borel Switzerland 22 1.1k 1.7× 412 0.8× 889 2.5× 303 1.2× 172 0.8× 63 3.2k
H. U. Schorlemmer Germany 27 608 0.9× 266 0.5× 751 2.1× 210 0.8× 120 0.5× 110 2.1k

Countries citing papers authored by George E. Moore

Since Specialization
Citations

This map shows the geographic impact of George E. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George E. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George E. Moore more than expected).

Fields of papers citing papers by George E. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George E. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George E. Moore. The network helps show where George E. Moore may publish in the future.

Co-authorship network of co-authors of George E. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of George E. Moore. A scholar is included among the top collaborators of George E. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George E. Moore. George E. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Moore, George E. & Harm HogenEsch. (2010). Adverse Vaccinal Events in Dogs and Cats. Veterinary Clinics of North America Small Animal Practice. 40(3). 393–407. 36 indexed citations
3.
Morse, Helvise G., et al.. (1994). Malignant melanoma: From subcutaneous nodule to brain metastasis. Cancer Genetics and Cytogenetics. 72(1). 16–23. 13 indexed citations
4.
Morse, Helvise G. & George E. Moore. (1993). Cytogenetic homogeneity in eight independent sites in a case of malignant melanoma. Cancer Genetics and Cytogenetics. 69(2). 108–112. 18 indexed citations
5.
Morse, Helvise G., René González, George E. Moore, & William A. Robinson. (1992). Preferential chromosome 11q and/or 17q aberrations in short-term cultures of metastatic melanoma in resections from human brain. Cancer Genetics and Cytogenetics. 64(2). 118–126. 21 indexed citations
6.
Kruse, Carol A., et al.. (1989). Interleukin-2—activated lymphocytes from brain tumor patients. A comparison of two preparations generatedin vitro. Cancer. 64(8). 1629–1637. 23 indexed citations
7.
Kuroki, Motomu, et al.. (1988). The Molecular Heterogeneity of Nonspecific Cross‐reacting Antigen Synthesized by Tumor Cells and Granulocytes. Japanese Journal of Cancer Research. 79(1). 82–90. 14 indexed citations
8.
Leung, Julia P., Walter A. Nelson‐Rees, George E. Moore, Relda Cailleau, & Thomas S. Edgington. (1981). Characteristics of membrane and cytosol forms of the mammary tumor glycoprotein molecule mtgp in human breast carcinoma cell cultures and tumors. International Journal of Cancer. 28(1). 35–42. 6 indexed citations
9.
Moore, George E.. (1978). Crisis in Scotland. The Howard Journal of Criminal Justice. 17(1). 32–40. 3 indexed citations
10.
Moore, George E., et al.. (1975). Identification of Lymphoid Cells in Cultures of Murine Leukocytes and Thymus. Cancer Research. 35(3). 673–678. 1 indexed citations
11.
Minowada, Jun, Meihan Nonoyama, George E. Moore, Alan Rauch, & Joseph S. Pagano. (1974). The presence of the Epstein-Barr viral genome in human lymphoblastoid B-cell lines and its absence in a myeloma cell line.. PubMed. 34(8). 1898–903. 36 indexed citations
12.
Moore, George E., et al.. (1973). Human cell line RPMI M7021 established from a liposarcoma. In Vitro Cellular & Developmental Biology - Plant. 9(3). 135–138. 6 indexed citations
13.
Han, Tin, Joseph E. Sokal, & George E. Moore. (1972). “Antigenic” disparity between cultured lymphoid cells and autologous lymphocytes. The American Journal of Medicine. 53(4). 437–445. 8 indexed citations
14.
Moore, George E., et al.. (1970). The incidence of ‘leukovirus’ in cultured human hematopoietic cells. Journal of Surgical Oncology. 2(4). 385–392. 2 indexed citations
15.
Matsuoka, Yuji, et al.. (1970). Heterotransplantation of a hematopoietic cell line derived from a patient with multiple myeloma.. PubMed. 30(6). 1850–6. 8 indexed citations
16.
Yagi, Yasuo, et al.. (1967). Antibodies against Human Leukemia Cell Lines. The Journal of Immunology. 98(2). 281–292. 9 indexed citations
17.
Bock, Fred G., et al.. (1964). Tumor-Promoting Activity of Extracts of Unburned Tobacco. Science. 145(3634). 831–833. 26 indexed citations
18.
Ishihara, Takaaki, George E. Moore, & Avery A. Sandberg. (1962). The in Vitro Chromosome Constitution of Cells from Human Tumors. Cancer Research. 22(3). 375–379. 49 indexed citations
19.
Moore, George E., et al.. (1962). Air-thermostated chamber with proportional temperature control for tissue culture application. Journal of Applied Physiology. 17(2). 356–358. 6 indexed citations
20.
Moore, George E., Hilton A. Smith, & Ellison H. Taylor. (1962). CATALYTIC REACTIONS ON SEMICONDUCTORS: HYDROGEN-DEUTERIUM EXCHANGE AND FORMIC ACID DECOMPOSITION ON CHEMICALLY DOPED GERMANIUM1. The Journal of Physical Chemistry. 66(7). 1241–1244. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026